The overuse and misuse
of antibiotics for decades increased evolutionary pressure on bacteria to
acquire antibiotic resistance. Resistant bacteria have a global reach and
infections claim at least 50,000 lives each year across Europe and the US.
The lack of detailed information on bacterial resistance profiles early in the patient management leads to the prescription of untargeted broad-spectrum antibiotics.
Our platform rapidly identifies the presence of key resistance markers such as methicilin, extended spectrum beta-lactamases and vancomycin, which will support clinicians to implement antibiotic stewardship programs.